Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29589922 | 1.00 | ZDHHC7 (0.55) | ZDHHC7TSHRSLC1A1KMT2AMEN1 | |
| SCHEMBL12358675 | 1.00 | ZDHHC7 (0.55) | ZDHHC7TSHRSLC1A1KMT2AMEN1 | |
| SCHEMBL9154081 | 0.88 | ZDHHC7 (0.61) | ZDHHC7TSHRSLC1A1KMT2AMEN1 | |
| SCHEMBL10929017 | 0.84 | ZDHHC7 (0.68) | ZDHHC7TSHRKMT2ALMNAALDH1A1 | |
| SCHEMBL5965786 | 0.84 | ZDHHC7 (0.65) | ZDHHC7TSHRKMT2ACA12CA14 | |
| SCHEMBL1415237 | 0.84 | ZDHHC7 (0.65) | ZDHHC7TSHRKMT2ACA12CA14 | |
| SCHEMBL28274656 | 0.83 | TSHR (0.41) | ZDHHC7TSHRSLC1A1KMT2AMEN1 | |
| SCHEMBL17754726 | 0.83 | ZDHHC7 (0.47) | ZDHHC7TSHRKMT2AMEN1CA12 | |
| SCHEMBL5556511 | 0.83 | ZDHHC7 (0.55) | ZDHHC7TSHRSLC1A1KDM4ECA1 | |
| SCHEMBL30081398 | 0.83 | ZDHHC7 (0.55) | ZDHHC7TSHRSLC1A1KDM4ECA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4722203-A1 | 3,4-DIHYDROPHTHALAZIN-1(2H)-ONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Academy of Military Medical Sciences (CN) | 2026-04-08 | — | — | EP | claimed |
| WO-2024251080-A1 | 3,4-DIHYDROPHTHALAZIN-1(2H)-ONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 中国人民解放军军事科学院军事医学研究院 | 2024-12-12 | — | — | WO | claimed |
| CN-117025117-B | High-temperature-resistant and deformation-resistant chip epoxy adhesive film and preparation method thereof | 青岛德聚胶接技术有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-117025117-A | High-temperature-resistant and deformation-resistant chip epoxy adhesive film and preparation method thereof | 青岛德聚胶接技术有限公司 | 2023-11-10 | — | — | CN | claimed |
| CN-116655591-A | 3, 4-dihydro phthalazine-1 (2H) -ketone derivative and preparation method and application thereof | 中国人民解放军军事科学院军事医学研究院 | 2023-08-29 | — | — | CN | claimed |
| US-20260103468-A1 | FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF | HAINAN SIMCERE ZAIMING PHARMACEUTICAL CO., LTD. (CN) | 2026-04-16 | — | — | US | disclosed |
| US-20260098043-A1 | POLYCYCLIC COMPOUND AND USE THEREOF | HAINAN SIMCERE ZAIMING PHARMECEUTICAL CO LTD (CN) | 2026-04-09 | — | — | US | disclosed |
| EP-4722203-A1 | 3,4-DIHYDROPHTHALAZIN-1(2H)-ONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Academy of Military Medical Sciences (CN) | 2026-04-08 | — | — | EP | disclosed |
| EP-4713329-A1 | NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING | Bayer Aktiengesellschaft (DE) | 2026-03-25 | — | — | EP | disclosed |
| US-12528814-B2 | Bifunctional degraders of interleukin-1 receptor-associated kinases and therapeutic use thereof | NURIX THERAPEUTICS, INC. (US) | 2026-01-20 | — | — | US | disclosed |
| US-20250367129-A1 | Lipid Compounds and Uses Thereof | PFIZER (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250360219-A1 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | ARVINAS OPERATIONS INC (US) | 2025-11-27 | — | — | US | disclosed |
| EP-0661279-B1 | Polyaminated ligands, metal complexes, process for their preparation and diagnostic and therapeutic applications | GUERBET SA (FR) | 2001-03-07 | — | — | EP | disclosed |
| US-6187285-B1 | IN PARTICULAR MAGNETIC RESONANCE IMAGING (MRI) FOR MAGNETIC CATIONS. | GUERBET (FR) | 2001-02-13 | — | — | US | disclosed |
| US-5919432-A | Polyaminated ligands and metal complexes thereof | GUERBET S.A. (FR) | 1999-07-06 | — | — | US | disclosed |
| US-5886158-A | Metal complexes of polyamino oxides, and their utilization in diagnostic imaging | GUERBET S.A. (FR) | 1999-03-23 | — | — | US | disclosed |
| CN-1189778-A | Metal complexes of polyaminoacids, and their utilization in diagnostic imaging | GUERBET SA (FR) | 1998-08-05 | — | — | CN | disclosed |
| US-5712389-A | Polyaminated ligands and metal complexes thereof | GUERBET S.A. (FR) | 1998-01-27 | — | — | US | disclosed |
| EP-0661279-A1 | Polyaminated ligands, metal complexes, process for their preparation and diagnostic and therapeutic applications | GUERBET S.A. (FR) | 1995-07-05 | — | — | EP | disclosed |
| EP-0480745-A2 | Substituted dihydrothieno-thiophene-2-sulfonamides and dioxides thereof | MERCK & CO. INC. (US) | 1992-04-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250360219-A1 | CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME | CRBN, CBL, MDM2 | ZDHHC7 3500/4885TSHR 3772/4885SLC1A1 3888/4885 |
| US-12528814-B2 | Bifunctional degraders of interleukin-1 receptor-associated kinases and therapeutic use thereof | IRAK1, IRAK2, IRAK3 | ZDHHC7 2160/4885TSHR 1625/4885SLC1A1 4118/4885 |
| US-20260098043-A1 | POLYCYCLIC COMPOUND AND USE THEREOF | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, NR3C2, NR3C1 | ZDHHC7 2213/4885TSHR 220/4885SLC1A1 3048/4885 |
| US-20260103468-A1 | FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF | NR3C2, CYP11B1, CYP11B2 | ZDHHC7 2356/4885TSHR 384/4885SLC1A1 1766/4885 |
| US-20250367129-A1 | Lipid Compounds and Uses Thereof | POLN, PHOSPHO1, NPC1 | ZDHHC7 490/4885TSHR 3471/4885SLC1A1 1824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.